Robotic Splenectomy for Sclerosing Angiomatoid Nodular Transformation

Massimo Arcerito^1, , Boris V Shlopov², Rafael Canseco³ and Thomas H Takei⁴

¹Riverside Medical Clinic Inc., Department of General and Vascular Surgery, Associate Clinical Professor, University of California Riverside, School of Medicine, 21634 Retreat Pkwy, Temescal Valley, CA 92883

²Director of Pathology, Department of Pathology, Corona Regional Medical Center, 800 S Main St, Corona CA, 92882

³Department of Surgery, Corona Regional Medical Center, 800 S Main St, Corona CA, 92882

⁴Riverside Medical Clinic, Department of Surgery, 7117 Brockton Ave, Riverside CA 92506

Cite this paper:
Massimo Arcerito, Boris V Shlopov, Rafael Canseco and Thomas H Takei. Robotic Splenectomy for Sclerosing Angiomatoid Nodular Transformation. American Journal of Medical Case Reports. 2022; 10(5):146-152. doi: 10.12691/ajmcr-10-5-7

Abstract

Splenic masses represent a clinical challenge when encountered by health care providers. These lesions must be excised completely and assessed histologically to differentiate benign and malignant diseases. Biopsy mass bleeding and false negative results are common. We report a 59 year old woman with no previous cancer history, with an incidental splenic mass found by abdominal ultrasound for left abdominal pain. Computer tomography scan and magnetic resonance imaging identified a solid nodular splenic lesion lacking definitive criteria for benign or malignant disease. Furthermore, liver/spleen scan ruled out hemangioma. After discussing the patient at tumor board, a robotic splenectomy was performed. The patient was discharged home 20 hours postoperatively. Sclerosing Angiomatoid Nodular Transformation (SANT) was confirmed by histology and immunohistochemistry. Imaging modalities are not helpful to clinch the diagnosis, leaving minimally invasive splenectomy and pathology to treat and assess this very rare splenic disease.

Keywords:
Splenic mass Robotic splenectomy Immunohistochemistry Triple Vessels Disease Sclerosing Angiomatoid Nodular Transformation

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

Figures

References:

[1]	Martel M, Cheuk W, Lombardi L, Lifschitz-Mercer B, Chan CJ, Rosai J. Sclerosing Angiomatoid Nodular Transformation (SANT): report 0f 25 cases of a distinctive benign splenic lesion. Am J Sure Pathol 2004; 28: 1268-1279.
[2]	Bamboat ZM, Masiakos PT. Sclerosing angiomatoid nodular transformation of the spleen in an adolescent with chronic abdominal pain. J Pediatr Surg. 2010 45: E13-6.
[3]	Koyama R, Minagawa N, Maeda Y, Shinohara T, Hamada T. A sclerosing angiomatoid nodular transformation (SANT) mimicking a metachronous splenic metastasis from endometrioid cancer and ovarian cancer. Int J Surg Case Rep. 2019 65: 292-5.
[4]	Aziret M, Yılmaz F, Kalpakçı Y, Subasi O, Senturk A, Karaman K et al. Sclerosing angiomatoid nodular transformation presenting with thrombocytopenia after laparoscopic splenectomy - Case report and systematic review of 230 patients. Ann of Med and Surg 60 (2020) 201-210.
[5]	Kaw YT, Duwaji MS, Knisley RE, Esparza AR. Hemangioendothelioma of the spleen. Arch Pathol Lab Med. 1992; 116: 1079-1082.
[6]	Fakan F, Michal M.Nodular transformation of splenic red pulp due to carcinomatous infiltration: a diagnostic pitfall. Histopathology. 1994; 25: 175-178.
[7]	Diebold J, Le Tourneau A, Marmey B, Prevot S, Muller-Hermelink HK, Sevestre H, et al. Is sclerosing angiomatoid nodular transformation (SANT) of the splenic red pulp identical to inflammatory pseudotumour? Report of 16 cases. Histopathology 2008, 53, 299-310.
[8]	Krishnan J, Danon A, Frizzera D. Use of anti-factor VIII-related antigen (F8) and QBEN10 (CD34) antibodies helps classify the benign vascular lesions of the spleen. Mod Pathol 1993; 6: 94A.
[9]	Chang KC, Lee JC, Wang YC, Hung LY, Huong Y, Huang WT, et al. Polyclonality in sclerosing angiomatoid nodular transformation of the spleen. Am J Surg Pathol. (2016) 40:1343-51.
[10]	Atas H, Bulus H, Akkurt G. Sclerosing Angiomatoid nodular transformation of the spleen: an uncommon cause of abdominal pain. Euroasian J Hepatogastroenterol 2017; 7: 89-91.
[11]	Raman SP, Singhi A, Horton KM, Hruban RH, Fishman EK. Sclerosing angiomatoid nodular transformation of the spleen (SANT): multimodality imaging appearance of five cases with radiology–pathology correlation. Abdom Imaging 2013; 38: 827-834.
[12]	Vigorito R, Scaramuzza D, Pellegrinelli A, Marchianò A. Sclerosing angiomatoid nodular transformation (SANT) of the spleen: A case report on CT and MRI. BJR Case Rep 2019; 5: 20180036.
[13]	Liao J, Wang Z, Li Q, Gou Z, Bai Xu, Kang H, et al. CT and MRI features of sclerosing angiomatoid nodular transformation of the spleen: A report of 18 patients with pathologic correlation. Diagnostic and Interventional Imaging 102 (2021) 389-396.
[14]	Ong BS, Thomas R. Sclerosing Angiomatoid Nodular Transformation (SANT): A Rare Splenic Tumor and Unusual Cause of Anemia.Am J Case Rep, 2021; 22: e933598 1-7.
[15]	Jin Y, Hu H, Regmi P, Li F, Cheng N. Treatment options for sclerosing angiomatoid nodular transformation of spleen. HPB 2020, 22, 1577-1582.
[16]	Weinreb I, Bailey D, Battaglia D,erez-Ordonez B. CD30 and Epstein-Barr virus RNA expression in sclerosing angiomatoid nodular transformation of spleen. Virchows Arch 2007; 451: 73-79.
[17]	Yoshii H, Izumi H, Nomi M, Tajiri T, Mukai M, Nomura E, et al. Sclerosing Angiomatoid Nodular Transformation of the Spleen: A Case Report. Tokai J Exp Clin Med 2020; 45(4): 236-242.